Black adults treated for common arterial disease are at greater risk of amputation, death than white adults, researchers show

About 6.5 million Americans over the age of 40 suffer from peripheral arterial disease (PAD). In the U.S., Black adults in their 50s are at least twice as likely to suffer from PAD as their white counterparts, a disparity that…
Female sex is associated with reintervention and mortality following elective EVAR

Women are more likely to die within five years of having elective surgery to repair an abdominal aortic aneurysm (AAA) or need repeat surgery, according to a recent study. Writing in the Journal of Vascular Surgery, Taylor Corsi, BS, a medical student at Rutgers University, Piscataway,…
Prepare for Board exams at UCLA/SVS review course

Planning to take the upcoming Vascular Surgery Board (VSB) exams? Prepare for them at the “Seventh Annual UCLA/SVS Symposium: A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery.” The course is coming up quickly. It will…
SVS PA Section seeks Steering Committee members

The Society for Vascular Surgery (SVS) Physician Assistant (PA) Section seeks applicants for its Steering Committee. The committee will be developing content for section members to help them improve patient care and quality. Applications are due Aug. 3. Learn more…
SVS looks to maintain AMA House of Delegates representation

To maintain its seat in the American Medical Association (AMA) House of Delegates—and, importantly, be able to provide information that impacts physician reimbursement—a 20% share of Society for Vascular Surgery (SVS) members must also maintain active membership at the AMA.…
Female sex is associated with additional treatments following surgery for intermittent claudication, study shows

A new U.S. study has found that female sex is associated with more reinterventions after surgical treatment for intermittent claudication. Additionally, guideline-directed medical therapy, including aspirin and statin use, was used less frequently among female compared with male patients in…
Cordis announces start of enrollment in RADIANCY clinical study in Europe

Cordis has announced the start of the European RADIANCY premarket clinical study of a stent system designed for radial access in the treatment of peripheral artery disease (PAD). RADIANCY is a prospective, multicenter, single-arm study to assess the safety and…
AVeVA study confirms benefit of covered stent placement in graft-vein anastomotic stenosis treatment
A prospective, multicenter study involving the Covera vascular covered stent (BD) has confirmed the benefits of immediate, post-percutaneous transluminal angioplasty (PTA) placement of the device in treating arteriovenous graft (AVG) venous anastomotic stenosis when anatomically and clinically suitable. Writing in the Journal…
The top 10 most popular Vascular Specialist items of June 2022

June’s top stories spanned a range of presentations from the 2022 Vascular Annual Meeting (VAM) in Boston (June 15–18), covering topics including burnout among vascular surgeons, amputation rates in Black and Hispanic CLTI patients, and VAM’s inaugural Women’s Section education…
PAD: Ra Medical Systems receives FDA 510(k) clearance for the Dabra 2.0 catheter

Ra Medical Systems has announced receipt of Food and Drug Administration (FDA) 510(k) clearance for the company’s Dabra 2.0 catheter as part of the Dabra excimer laser system for the treatment of peripheral arterial disease (PAD). A company press release…

